Literature DB >> 17177441

Elucidation of hydrolysis mechanisms for fatty acid amide hydrolase and its Lys142Ala variant via QM/MM simulations.

Ivan Tubert-Brohman1, Orlando Acevedo, William L Jorgensen.   

Abstract

Fatty acid amide hydrolase (FAAH) is a serine hydrolase that degrades anandamide, an endocannabinoid, and oleamide, a sleep-inducing lipid, and has potential applications as a therapeutic target for neurological disorders. Remarkably, FAAH hydrolyzes amides and esters with similar rates; however, the normal preference for esters reemerges when Lys142 is mutated to alanine. To elucidate the hydrolysis mechanisms and the causes behind this variation of selectivity, mixed quantum and molecular mechanics (QM/MM) calculations were carried out to obtain free-energy profiles for alternative mechanisms for the enzymatic hydrolyses. The methodology features free-energy perturbation calculations in Monte Carlo simulations with PDDG/PM3 as the QM method. For wild-type FAAH, the results support a mechanism, which features proton transfer from Ser217 to Lys142, simultaneous proton transfer from Ser241 to Ser217, and attack of Ser241 on the substrate's carbonyl carbon to yield a tetrahedral intermediate, which subsequently undergoes elimination with simultaneous protonation of the leaving group by a Lys142-Ser217 proton shuttle. For the Lys142Ala mutant, a striking multistep sequence is proposed with simultaneous proton transfer from Ser241 to Ser217, attack of Ser241 on the carbonyl carbon of the substrate, and elimination of the leaving group and its protonation by Ser217. Support comes from the free-energy results, which well reproduce the observation that the Lys142Ala mutation in FAAH decreases the rate of hydrolysis for oleamide significantly more than for methyl oleate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17177441     DOI: 10.1021/ja065863s

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  21 in total

1.  Evaluation and ranking of enzyme designs.

Authors:  Gert Kiss; Daniela Röthlisberger; David Baker; K N Houk
Journal:  Protein Sci       Date:  2010-09       Impact factor: 6.725

2.  Covalent inhibitors of fatty acid amide hydrolase: a rationale for the activity of piperidine and piperazine aryl ureas.

Authors:  Giulia Palermo; Davide Branduardi; Matteo Masetti; Alessio Lodola; Marco Mor; Daniele Piomelli; Andrea Cavalli; Marco De Vivo
Journal:  J Med Chem       Date:  2011-09-08       Impact factor: 7.446

3.  Hybrid dynamics simulation engine for metalloproteins.

Authors:  Manuel Sparta; David Shirvanyants; Feng Ding; Nikolay V Dokholyan; Anastassia N Alexandrova
Journal:  Biophys J       Date:  2012-08-22       Impact factor: 4.033

4.  Application of a SCC-DFTB QM/MM approach to the investigation of the catalytic mechanism of fatty acid amide hydrolase.

Authors:  Luigi Capoferri; Marco Mor; Jitnapa Sirirak; Ewa Chudyk; Adrian J Mulholland; Alessio Lodola
Journal:  J Mol Model       Date:  2011-03-02       Impact factor: 1.810

5.  Fluoride-mediated capture of a noncovalent bound state of a reversible covalent enzyme inhibitor: X-ray crystallographic analysis of an exceptionally potent α-ketoheterocycle inhibitor of fatty acid amide hydrolase.

Authors:  Mauro Mileni; Joie Garfunkle; Cyrine Ezzili; Benjamin F Cravatt; Raymond C Stevens; Dale L Boger
Journal:  J Am Chem Soc       Date:  2011-02-28       Impact factor: 15.419

6.  Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics.

Authors:  Cyrine Ezzili; Mauro Mileni; Nicholas McGlinchey; Jonathan Z Long; Steven G Kinsey; Dustin G Hochstatter; Raymond C Stevens; Aron H Lichtman; Benjamin F Cravatt; Edward J Bilsky; Dale L Boger
Journal:  J Med Chem       Date:  2011-03-23       Impact factor: 7.446

7.  Quantum mechanics/molecular mechanics modeling of fatty acid amide hydrolase reactivation distinguishes substrate from irreversible covalent inhibitors.

Authors:  Alessio Lodola; Luigi Capoferri; Silvia Rivara; Giorgio Tarzia; Daniele Piomelli; Adrian Mulholland; Marco Mor
Journal:  J Med Chem       Date:  2013-03-07       Impact factor: 7.446

8.  X-ray crystallographic analysis of alpha-ketoheterocycle inhibitors bound to a humanized variant of fatty acid amide hydrolase.

Authors:  Mauro Mileni; Joie Garfunkle; Cyrine Ezzili; F Scott Kimball; Benjamin F Cravatt; Raymond C Stevens; Dale L Boger
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

9.  Origin of the activity drop with the E50D variant of catalytic antibody 34E4 for Kemp elimination.

Authors:  Anastassia N Alexandrova; William L Jorgensen
Journal:  J Phys Chem B       Date:  2009-01-15       Impact factor: 2.991

10.  Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl alkylcarbamates.

Authors:  Marco Mor; Alessio Lodola; Silvia Rivara; Federica Vacondio; Andrea Duranti; Andrea Tontini; Silvano Sanchini; Giovanni Piersanti; Jason R Clapper; Alvin R King; Giorgio Tarzia; Daniele Piomelli
Journal:  J Med Chem       Date:  2008-05-29       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.